The device can be compressed to half its original size and expand to conform to a variety of spaces for surgical flexibility. The bone graft can be used during spinal fusion or general orthopedic surgeries instead of using bone graft material harvested from the patient’s body.
Read the Integra LifeSciences release on the Integra Allograft Cancellous Sponge.
Read other coverage on Integra LifeSciences:
– Integra LifeSciences Introduces New Retraction System for Minimally Invasive Spine Surgery
– DiFUSE Technologies Receives FDA Clearance for Spinal Fusion System
– Integra LifeSciences Reports 8% Increase in Total Revenue
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
